Medical News

RSS

Golden Meditech applies for listing of TDR on Taiwan Stock Exchange

Golden Meditech Holdings Limited, mainland China's leading integrated healthcare enterprise, is pleased to announce today that the Company has made an application to the Taiwan Stock Exchange and the Taiwan Central Bank for the offering and listing of up to 90 million units of Taiwan Depositary Receipts equivalent to no more than 180 million shares of the Group).

6 Oct 2010

American Specialty Health and Healthyroads move to San Diego's Sorrento Mesa business district

It's moving month for health and wellness company American Specialty Health Incorporated (ASH) and its subsidiaries, including wellness company Healthyroads. ASH will be vacating its 156,000 square feet of existing office space in downtown San Diego and transitioning to a 20 percent larger campus environment, comprised of an 81,000 square-foot building to house Healthyroads and a 107,000 square foot building for ASH's other programs. The new buildings, which ASH will occupy for the next 10 years, are located in San Diego's Sorrento Mesa business district.

6 Oct 2010

ISTA Pharmaceuticals announces Phase 1/2 clinical study results of bepotastine besilate nasal spray

ISTA Pharmaceuticals, Inc., today announced positive preliminary results from a Phase 1/2 clinical study of bepotastine besilate nasal spray conducted in Canada for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies.

6 Oct 2010

NBF's Brilliance in Bipolar Initiative receives Congressman Kennedy's endorsement

Congressman Patrick Kennedy, a long-time advocate for people living with mental illness, and Marc Kullman, co-founder of the National Bipolar Foundation, joined efforts to help reduce the stigma associated with bipolar disorder. The Brilliance in Bipolar Initiative is a national and collaborative effort to draw attention to and develop a better understanding of bipolar disorder.

6 Oct 2010

Synergy reports positive results from plecanatide Phase IIa clinical trial for chronic constipation

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today positive results in a Phase IIa clinical trial of plecanatide (SP-304) in patients with chronic constipation. Oral plecanatide given once daily, over 14 consecutive days, at doses of 0.3, 1.0, 3.0 and 9.0 mg gave improved bowel function in patients with chronic constipation.

6 Oct 2010

ATR product improves clinical outcome in patients with soft tissue defects in foot

Reported cases, by Dr. Jan Lidström, which involve 20 patients with soft tissue defects in the foot with up to four years follow-up together with a biomechanical study, by Dr. Eric Giza, confirm the positive clinical outcome orthopedic foot surgeons have experienced with Artelon Tissue Reinforcement (ATR).

6 Oct 2010

First Edition: October 6, 2010

Today's headlines include reports about the early legal tests facing the new health law and more on the politics swirling around the measure's sweeping reforms.

6 Oct 2010

U.N. calls for increased efforts to reduce urban poverty, improve city living conditions

The U.N. marked World Habitat Day Monday with a call for governments worldwide to do more to reduce urban poverty and improve the living conditions that populations in cities around the world face, Kenya Broadcasting Corporation reports.

6 Oct 2010

Adeona completes enrollment in Part 2 CopperProof-2 clinical study

Adeona Pharmaceuticals, Inc., announced completion of 100% enrollment in Part 2 of its clinical study, A Prospective, Randomized, Double Blind Trial of a Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease (CopperProof-2).

6 Oct 2010

Androgen deprivation therapy for prostate cancer associated with structural bone decay

Using novel technology allowing "virtual bone biopsies" researchers have found that a common treatment for prostate cancer called androgen deprivation therapy (ADT) is associated with structural decay of cortical and trabecular bone. The study has been accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

6 Oct 2010

Pathwork Diagnostics closes $30M Series C financing

Pathwork Diagnostics, Inc, a privately held molecular diagnostics company focused on oncology, today announced the closing of its $30 million Series C financing. Led by Alta Partners, the financing included participation from the company's existing investors: Abingworth, Advent Venture Partners, Novus Ventures, Prospect Venture Partners and Venrock.

6 Oct 2010

Ibuprofen provides pain relief within two hours in 49% of migraine sufferers

For many people suffering from migraine headaches, over-the-counter ibuprofen - Advil and Motrin are well-known brands - might be enough to relieve the pain.

6 Oct 2010

Innovacell invests 10 million Euros for clinical development

In a new round of financing, shareholders of Innsbruck's Innovacell Biotechnologie AG agreed on September 27th to make 4.3 million Euros worth of fresh capital available to the company. Financing of the current Phase IIb multi-centre study for urocell is thus totally secured," explained CEO Ekkehart Steinhuber.

6 Oct 2010

Elsevier launches new publishing model to enhance publication process

Elsevier, the world-leading publisher of scientific, technical and medical information products and solutions, announced today the launch of Article-Based Publishing a new publishing model that publishes articles as final and citable without needing to wait until a journal issue is complete.

6 Oct 2010

FDA clears Integra LifeSciences' Vu aPOD Prime anterior lumbar interbody fusion device

Integra LifeSciences announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Vu aPOD™ Prime anterior lumbar interbody fusion (ALIF) device.

6 Oct 2010

IVF pioneer wins Nobel prize three decades after groundbreaking work

Yesterday's announcement that a pioneer of in vitro fertilization (IVF) for humans has won the Nobel prize for medicine three decades after his groundbreaking work adds new historical perspective to advancements in reproductive medicine, a sharp reminder of how a once-feared technology has transformed into a highly popular and routine treatment for infertility, said one of Southern California's earliest fertility doctors.

6 Oct 2010

Research to focus on effective use of artemisinin stocks for malaria

The frontline malaria treatment artemisinin could soon be treating more people for less cost, thanks to a research collaboration between Bradford and Shanghai.

6 Oct 2010

iMDsoft to install MetaVision clinical information system across Queensland's network of public hospitals

iMDsoft® announced today that the Government of Queensland has signed an agreement to install MetaVision® in selected ICUs across the state's network of public hospitals. MetaVision will be installed in 14 hospitals and will be implemented in a diverse range of ICU settings including pediatric, neurology and cardiac units. The university-affiliated Gold Coast Hospital will be the first to implement MetaVision under this agreement.

6 Oct 2010

Hypertonic fluids do not improve outcomes or survival for severe traumatic brain injury: Study

Patients with a severe traumatic brain injury (and not in shock because of blood loss) who received out-of-hospital administration of hypertonic fluids (a solution with increased concentration of certain electrolytes and thought to help reduce intracranial pressure) as initial resuscitation did not experience better 6-month neurologic outcomes or survival compared to patients who received a normal saline solution, according to a study in the October 6 issue of JAMA.

6 Oct 2010

Health overhaul implementation updates: States fret, Sebelius hits The Hill

In a congressional appearance Monday, Health and Human Services Secretary Kathleen Sebelius asked lawmakers to move beyond politics and focus on successfully reforming American health care.

6 Oct 2010

Medical News

Golden Meditech applies for listing of TDR on Taiwan Stock Exchange

American Specialty Health and Healthyroads move to San Diego's Sorrento Mesa business district

ISTA Pharmaceuticals announces Phase 1/2 clinical study results of bepotastine besilate nasal spray

NBF's Brilliance in Bipolar Initiative receives Congressman Kennedy's endorsement

Synergy reports positive results from plecanatide Phase IIa clinical trial for chronic constipation

ATR product improves clinical outcome in patients with soft tissue defects in foot

First Edition: October 6, 2010

U.N. calls for increased efforts to reduce urban poverty, improve city living conditions

Adeona completes enrollment in Part 2 CopperProof-2 clinical study

Androgen deprivation therapy for prostate cancer associated with structural bone decay

Pathwork Diagnostics closes $30M Series C financing

Ibuprofen provides pain relief within two hours in 49% of migraine sufferers

Innovacell invests 10 million Euros for clinical development

Elsevier launches new publishing model to enhance publication process

FDA clears Integra LifeSciences' Vu aPOD Prime anterior lumbar interbody fusion device

IVF pioneer wins Nobel prize three decades after groundbreaking work

Research to focus on effective use of artemisinin stocks for malaria

iMDsoft to install MetaVision clinical information system across Queensland's network of public hospitals

Hypertonic fluids do not improve outcomes or survival for severe traumatic brain injury: Study

Health overhaul implementation updates: States fret, Sebelius hits The Hill

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News